Skip to main content
FEMY
NASDAQ Life Sciences

$30M Private Placement Led by Nantahala Could Bring Up to $90M to Femasys

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$2.68
Mkt Cap
$8.092M
52W Low
$2.6
52W High
$22.2
52W Position info
3.1% above low
Off High info
88% below high
Rel. Volume info
3.8× avg
Market data snapshot near publication time

FEMY is trading near its 52-week low of $2.6 (3.1% above the low) on elevated volume (3.8× avg).

Summary

Femasys secures a $30M private placement at $3.20 per share, a premium to the $2.68 market price, signaling strong institutional demand. The deal includes warrants that could bring total proceeds to $90M if fully exercised, with milestone warrants tied to hitting $1.5M in quarterly U.S. revenue and a 130% VWAP trigger. This financing follows the June reverse split and Nasdaq compliance, providing runway to advance the FemBloc clinical program and commercialize the fertility portfolio. The participation of Nantahala Capital and Rosalind Advisors adds credibility, and management's own investment underscores internal conviction. The capital infusion addresses the going concern risk flagged in the last 10-Q, though dilution from potential warrant exercise is significant.

Updates

  1. · SEC 8-K — The private placement closed on August 10, 2026. Nantahala Capital received the right to appoint up to two board members and a non-voting observer, subject to ownership thresholds, and gained protective provisions including consent rights over CEO changes and debt above $2.5 million.

At the time of this announcement, FEMY was trading at $2.68 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $8.1M. The 52-week trading range was $2.60 to $22.20. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

FEMY - Latest Insights

FEMY
Nov 13, 2026, 4:54 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $1.44
Real-time Price: $1.24 info
Change: -$0.200 (-14%) info
Market Cap: $10.734M info
FEMY
Sep 29, 2026, 7:02 AM EDT
Filing Type: 424B3
Importance Score:
8
Price at Filing: $2.38
Real-time Price: $1.24 info
Change: -$1.14 (-48%) info
Market Cap: $10.734M info
FEMY
Sep 03, 2026, 5:06 PM EDT
Filing Type: S-3
Importance Score:
7
Price at Filing: $3.04
Real-time Price: $1.24 info
Change: -$1.80 (-59%) info
Market Cap: $10.734M info
FEMY
Aug 26, 2026, 9:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $2.88
Real-time Price: $1.24 info
Change: -$1.64 (-57%) info
Market Cap: $10.734M info
FEMY
Aug 19, 2026, 9:02 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $2.15
Real-time Price: $1.24 info
Change: -$0.910 (-42%) info
Market Cap: $10.734M info